HK Stock MarketDetailed Quotes
01011 NT PHARMA
- 0.300
- +0.020+7.14%
Market Closed Nov 15 16:08 CST
79.23MMarket Cap-526P/E (TTM)
0.320High0.300Low336.50KVolume0.300Open0.280Pre Close101.61KTurnover0.13%Turnover RatioLossP/E (Static)264.09MShares1.40052wk High-0.21P/B79.23MFloat Cap0.17052wk Low--Dividend TTM264.09MShs Float42.200Historical High--Dividend LFY7.14%Amplitude0.170Historical Low0.301Avg Price10000Lot Size--Div YieldTTM--Div Yield LFY
NT PHARMA Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 324.88%31.3M | --7.37M | -93.89%7.37M | ---- | 8.33%120.5M | 2.24%226.7M | 24.37%111.23M | -39.41%221.73M | -4.88%89.44M | -35.97%365.97M |
| Operating income | 324.88%31.3M | 7.37M | -93.89%7.37M | 8.33%120.5M | 2.24%226.7M | 24.37%111.23M | -39.41%221.73M | -4.88%89.44M | -35.97%365.97M | |
| Cost of sales | ---25.59M | ---- | ---- | ---- | -15.31%-45.63M | 6.43%-81.24M | -20.87%-39.57M | 17.38%-86.83M | 0.15%-32.74M | 29.72%-105.09M |
| Operating expenses | -25.59M | -15.31%-45.63M | 6.43%-81.24M | -20.87%-39.57M | 17.38%-86.83M | 0.15%-32.74M | 29.72%-105.09M | |||
| Gross profit | -22.54%5.71M | -90.16%7.37M | 4.48%74.87M | 7.82%145.46M | 26.39%71.66M | -48.29%134.9M | -7.41%56.7M | -38.18%260.88M | ||
| Selling expenses | ---55K | ---- | ---- | ---- | 7.04%-48.75M | ---- | -36.47%-52.44M | ---- | 6.39%-38.43M | ---- |
| Administrative expenses | 30.31%-7.05M | -181.03%-63.57M | 61.61%-10.11M | ---22.62M | 27.21%-26.33M | ---- | 18.53%-36.18M | ---- | -16.91%-44.4M | ---- |
| Profit from asset sales | ---- | --12.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 16,209.09%1.79M | ---- |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 16,209.09%1.79M | ---- |
| Impairment and provision | ---- | ---- | ---- | ---3.92M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | ---- | ---- | ---3.92M | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | 29,000.00%291K | -65.82%2.35M | -99.99%1K | -65.98%6.86M | -82.79%7.79M | -25.27%20.18M | 1,468.98%45.27M | 1,046.94%27M | 163.84%2.89M | 97.32%2.35M |
| Operating profit | 59.77%-1.1M | -111.35%-41.59M | -136.16%-2.74M | -111.88%-19.68M | -73.21%7.58M | 2.31%165.64M | 231.97%28.31M | -38.50%161.9M | 3.80%-21.45M | -37.80%263.24M |
| Financing cost | 54.13%-6.01M | 26.79%-28.82M | 62.46%-13.09M | 55.63%-39.37M | -9.30%-34.87M | -2.53%-88.73M | -17.96%-31.9M | 17.09%-86.54M | -22.24%-27.05M | -28.77%-104.38M |
| Share of profits of associates | -28.49%7.89M | 311.41%37.04M | --11.04M | -73.90%9M | ---- | 431,025.00%34.49M | ---- | 129.63%8K | ---- | 98.63%-27K |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | 5.63%-260.15M | ---- | 62.86%-275.66M | ---- | 17.72%-742.31M |
| Earning before tax | 116.37%785K | 33.32%-33.37M | 82.43%-4.8M | 66.36%-50.04M | -659.29%-27.29M | 25.73%-148.75M | 92.59%-3.59M | 65.67%-200.29M | -9.17%-48.5M | -3.82%-583.47M |
| Tax | ---124K | ---122K | ---- | ---- | ---949K | -128.63%-2.58M | ---- | 192.70%9.02M | ---- | 75.59%-9.73M |
| After-tax profit from continuing operations | 113.78%661K | 33.07%-33.49M | 83.02%-4.8M | 66.93%-50.04M | -685.70%-28.24M | 20.88%-151.33M | 92.59%-3.59M | 67.76%-191.27M | -9.04%-48.5M | 1.44%-593.2M |
| After-tax profit from non-continuing business | ---- | -572.77%-110.1M | ---816K | ---16.37M | ---- | ---- | ---- | ---168.64M | -175.68%-36.46M | ---- |
| Earning after tax | 111.78%661K | -116.23%-143.59M | 80.13%-5.61M | 56.12%-66.41M | -685.70%-28.24M | 57.95%-151.33M | 95.77%-3.59M | 39.33%-359.91M | -2,396.24%-84.96M | 38.45%-593.2M |
| Minority profit | ---- | ---- | ---- | ---- | ---- | 22.39%-1.8M | 46.41%-940K | 58.77%-2.31M | -66.89%-1.75M | 7.94%-5.61M |
| Shareholders should account for profits from continuing business | 113.78%661K | 33.07%-33.49M | ---4.8M | ---50.04M | ---- | ---- | ---- | ---- | ---46.75M | ---- |
| Shareholders should account for profits from non-continuing business | ---- | -572.77%-110.1M | ---816K | ---16.37M | ---- | ---- | ---- | ---- | ---36.46M | ---- |
| Profit attributable to shareholders | 111.78%661K | -116.23%-143.59M | 80.13%-5.61M | 55.59%-66.41M | -963.98%-28.24M | 58.18%-149.54M | 96.81%-2.65M | 39.14%-357.6M | -1,851.36%-83.21M | 38.64%-587.59M |
| Basic earnings per share | 112.00%0.0003 | -108.02%-0.0726 | 83.22%-0.0025 | 55.88%-0.0349 | -964.29%-0.0149 | 58.26%-0.0791 | 96.80%-0.0014 | 43.11%-0.1895 | -1,660.71%-0.0437 | 45.54%-0.3331 |
| Diluted earnings per share | 112.00%0.0003 | -108.02%-0.0726 | 83.22%-0.0025 | 55.88%-0.0349 | -964.29%-0.0149 | 58.26%-0.0791 | 96.80%-0.0014 | 43.11%-0.1895 | -1,660.71%-0.0437 | 45.54%-0.3331 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data